Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-05-01

FDA Approved: TESTIM — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TESTIM (testosterone gel) by Endo USA, Inc., resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTIM (TESTOSTERONE)

Snippet

SUPPL AP for TESTIM (TESTOSTERONE)